Intra-Cellular Therapies Inc. (ITCI) Declined -5.15% or -0.73 To Price $13.44 On Tuesday


Intra-Cellular Therapies Inc. (ITCI) declined -5.15% or -0.73 to $13.44. It is around 148451 shares traded, which is 51.32% compare to the average total volume 289256. The market cap of ITCI is $741.01 million. The year to date change is 17.85%. The 52 week price range is from $10.21 to $23.64. Price of ITCI have changed 7.59% during last week. It have changed 6.86% over last month, 8.42% over last 3 months, -23.61% over last 6 months and -27.85% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ITCI is 12.95. It is -3.65% below current price. The 200-day Moving Averages for ITCI is 16.08. It is 19.64% above current price. The 52-week High is 23.64. It is 75.89% from the current price. The 52-week Low is 10.21. It is -24.03% from current price.

There are some statistics of ITCI. It is has market cap $741.01 million. The share outstanding is 55.13 million. The average volume is 289256. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ITCI is -40.18%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ITCI is -37.44%.


Tags:

Share this post